F. Lerebours and R. Lidereau, Molecular alterations in sporadic breast cancer, Critical Reviews in Oncology/Hematology, vol.44, issue.2, pp.121-141, 2002.
DOI : 10.1016/S1040-8428(01)00191-3

F. Esteva and G. Hortobagyi, Prognostic molecular markers in early breast cancer, Breast Cancer Research, vol.3, issue.3, pp.109-118, 2004.
DOI : 10.1038/nrc1043

F. Janicke, A. Prechtl, C. Thomssen, N. Harbeck, C. Meisner et al., Randomized Adjuvant Chemotherapy Trial in High-Risk, Lymph Node-Negative Breast Cancer Patients Identified by Urokinase-Type Plasminogen Activator and Plasminogen Activator Inhibitor Type 1, JNCI Journal of the National Cancer Institute, vol.93, issue.12, pp.913-920, 2001.
DOI : 10.1093/jnci/93.12.913

J. Derisi, L. Penland, P. Brown, M. Bittner, P. Meltzer et al., Use of a cDNA microarray to analyse gene expression patterns in human cancer, Nat Genet, vol.14, pp.457-460, 1996.

Q. Guo, DNA microarray and cancer, Current Opinion in Oncology, vol.15, issue.1, pp.36-43, 2003.
DOI : 10.1097/00001622-200301000-00005

I. Bieche, B. Parfait, I. Laurendeau, I. Girault, M. Vidaud et al., Quantification of estrogen receptor ?? and ?? expression in sporadic breast cancer, Oncogene, vol.20, issue.56, pp.8109-8115, 2001.
DOI : 10.1038/sj.onc.1204917

J. Hanley and B. Mcneil, The meaning and use of the area under a receiver operating characteristic (ROC) curve., Radiology, vol.143, issue.1, pp.29-36, 1982.
DOI : 10.1148/radiology.143.1.7063747

G. Didier, P. Brezellec, R. E. Henaut, and A. , GeneANOVA--gene expression analysis of variance, Bioinformatics, vol.18, issue.3, pp.490-491, 2002.
DOI : 10.1093/bioinformatics/18.3.490

E. Kaplan and P. Meier, Nonparametric Estimation from Incomplete Observations, Journal of the American Statistical Association, vol.37, issue.282, pp.457-481, 1958.
DOI : 10.1214/aoms/1177731566

R. Peto, M. Pike, P. Armitage, N. Breslow, D. Cox et al., Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples, British Journal of Cancer, vol.35, issue.1, pp.1-39, 1977.
DOI : 10.1038/bjc.1977.1

D. Cox, Regression Models and Life-Tables, J R Stat Soc (B), vol.34, pp.187-220, 1972.
DOI : 10.1007/978-1-4612-4380-9_37

I. Bieche, P. Onody, S. Tozlu, K. Driouch, M. Vidaud et al., family mRNA expression in breast carcinomas, International Journal of Cancer, vol.18, issue.5, pp.758-765, 2003.
DOI : 10.1002/ijc.11273

I. Bieche, I. Laurendeau, S. Tozlu, M. Olivi, D. Vidaud et al., Quantitation of MYC gene expression in sporadic breast tumors with a real-time reverse transcription-PCR assay, Cancer Res, vol.59, pp.2759-2765, 1999.

I. Bieche, C. Nogues, V. Paradis, M. Olivi, P. Bedossa et al., Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcriptionpolymerase chain reaction assay, Clin Cancer Res, vol.6, pp.452-459, 2000.

I. Bieche, M. Olivi, C. Nogues, M. Vidaud, and R. Lidereau, Prognostic value of CCND1 gene status in sporadic breast tumours, as determined by real-time quantitative PCR assays, British Journal of Cancer, vol.12, issue.4, pp.580-586, 2002.
DOI : 10.1038/sj.bjc.6600109

I. Bieche, B. Parfait, D. Le, M. Olivi, M. Rio et al., Identification of CGA as a novel estrogen receptor-responsive gene in breast cancer: an outstanding candidate marker to predict the response to endocrine therapy, Cancer Res, vol.61, pp.1652-1658, 2001.

I. Bieche, B. Parfait, S. Tozlu, R. Lidereau, and M. Vidaud, Quantitation of androgen receptor gene expression in sporadic breast tumors by real-time RT-PCR: evidence that MYC is an AR-regulated gene, Carcinogenesis, vol.22, issue.9, pp.1521-1526, 2001.
DOI : 10.1093/carcin/22.9.1521

I. Girault, S. Tozlu, R. Lidereau, and I. Bieche, Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas, Clin Cancer Res, vol.9, pp.4415-4422, 2003.

F. Spyratos, C. Bouchet, S. Tozlu, M. Labroquere, S. Vignaud et al., Prognostic value of uPA, PAI-1 and PAI-2 mRNA expression in primary breast cancer, Anticancer Res, vol.22, pp.2997-3003, 2002.

D. Zajchowski, M. Bartholdi, Y. Gong, L. Webster, H. Liu et al., Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells, Cancer Res, vol.61, pp.5168-5178, 2001.

T. Sorlie, C. Perou, R. Tibshirani, T. Aas, S. Geisler et al., Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications, Proceedings of the National Academy of Sciences, vol.179, issue.1, pp.10869-10874, 2001.
DOI : 10.1002/(SICI)1096-9896(199605)179:1<31::AID-PATH523>3.0.CO;2-O

M. West, C. Blanchette, H. Dressman, E. Huang, S. Ishida et al., Predicting the clinical status of human breast cancer by using gene expression profiles, Proceedings of the National Academy of Sciences, vol.11, issue.1, pp.11462-11467, 2001.
DOI : 10.1016/0303-7207(96)03844-0

F. Bertucci, V. Nasser, S. Granjeaud, F. Eisinger, A. J. Tagett et al., Gene expression profiles of poor-prognosis primary breast cancer correlate with survival, Human Molecular Genetics, vol.11, issue.8, pp.863-872, 2002.
DOI : 10.1093/hmg/11.8.863

M. Van-de-vijver, Y. He, . Van-'t, L. Veer, H. Dai et al., A Gene-Expression Signature as a Predictor of Survival in Breast Cancer, New England Journal of Medicine, vol.347, issue.25, pp.1999-2009, 2002.
DOI : 10.1056/NEJMoa021967

E. Huang, S. Cheng, H. Dressman, J. Pittman, M. Tsou et al., Gene expression predictors of breast cancer outcomes, The Lancet, vol.361, issue.9369, pp.1590-1596, 2003.
DOI : 10.1016/S0140-6736(03)13308-9

T. Jenssen, W. Kuo, T. Stokke, and E. Hovig, Associations between gene expressions in breast cancer and patient survival, Hum Genet, vol.111, pp.411-420, 2002.

A. Ho and S. Dowdy, Regulation of G1 cell-cycle progression by oncogenes and tumor suppressor genes, Current Opinion in Genetics & Development, vol.12, issue.1, pp.47-52, 2002.
DOI : 10.1016/S0959-437X(01)00263-5

R. Donnellan, I. Kleinschmidt, and R. Chetty, Cyclin E immunoexpression in breast ductal carcinoma: Pathologic correlations and prognostic implications, Human Pathology, vol.32, issue.1, pp.89-94, 2001.
DOI : 10.1053/hupa.2001.21141

M. Loden, M. Stighall, N. Nielsen, G. Roos, S. Emdin et al., The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node, Oncogene, vol.21, issue.30, pp.4680-4690, 2002.
DOI : 10.1038/sj.onc.1205578

K. Keyomarsi, S. Tucker, T. Buchholz, M. Callister, Y. Ding et al., Cyclin E and Survival in Patients with Breast Cancer, New England Journal of Medicine, vol.347, issue.20, pp.1566-1575, 2002.
DOI : 10.1056/NEJMoa021153

P. Span, V. Tjan-heijnen, P. Manders, L. Beex, and C. Sweep, Cyclin-E is a strong predictor of endocrine therapy failure in human breast cancer, Oncogene, vol.22, issue.31, pp.4898-4904, 2003.
DOI : 10.1038/sj.onc.1206818

J. Rajan, M. Wang, S. Marquis, and L. Chodosh, Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells, Proceedings of the National Academy of Sciences, vol.88, issue.6, pp.13078-13083, 1996.
DOI : 10.1093/jnci/88.6.365

J. Vaughn, F. Cirisano, G. Huper, A. Berchuck, P. Futreal et al., Cell cycle control of BRCA2, Cancer Res, vol.56, pp.4590-4594, 1996.

C. Egawa, Y. Miyoshi, T. Taguchi, Y. Tamaki, and S. Noguchi, HighBRCA2 mRNA expression predicts poor prognosis in breast cancer patients, International Journal of Cancer, vol.73, issue.6, pp.879-882, 2002.
DOI : 10.1002/ijc.10231

P. Jones and S. Baylin, The fundamental role of epigenetic events in cancer, Nat Rev Genet, vol.3, pp.415-428, 2002.